Moon Sook, Kim Do Kyeong, Kim Jin
Department of Dental Hygiene, College of Nursing Healthcare, Sorabol College, Gyeongju 38063, Republic of Korea.
Oral Cancer Research Institute, Department of Oral Pathology, Yonsei University College of Dentistry, Seoul 03722, Republic of Korea.
Oncotarget. 2017 May 23;8(21):35184-35192. doi: 10.18632/oncotarget.17059.
MicroRNAs (miRNAs) regulate key biological processes, and their aberrant expression has been related to cancer development. Photodynamic therapy (PDT) has emerged as one of the most promising modalities for cancer treatment. However, the application of PDT has been limited to superficially localized human cancerous and precancerous lesions. To increase the usefulness of both PDT and miRNAs in cancer therapy, this study investigated whether apoptosis-related miRNA expression is influenced by PDT in oral cancer and whether miRNAs can enhance PDT efficacy. To achieve this goal, we performed a miRNA array-based comparison of apoptosis-related miRNA expression patterns following PDT using pheophorbide a (Pa) as a photosensitizer. After Pa-PDT, 13.1% of the miRNAs were down-regulated, and 16.7% of the miRNAs were up-regulated. Representative miRNAs were selected according to expression difference: miR-9-5p, miR-32-5p, miR-143-3p, miR-145-5p, miR-192-5p, miR-193a-5p, miR-204-5p, miR-212-3p, miR-338-3p, and miR-451a. Among them, only miR-145-5p showed the consistent reduction repeatedly in all cell lines after Pa-PDT. Further, the combined treatment of a miR-145-5p mimic and Pa-PDT increased phototoxicity, reactive oxygen species generation, and apoptotic cell death, suggesting that miRNAs expression could be a useful marker for enhancing the therapeutic effect of Pa-PDT. This study will provide a promising strategy for introducing miRNA as cancer therapy.
微小RNA(miRNA)调控关键生物学过程,其异常表达与癌症发展相关。光动力疗法(PDT)已成为最具前景的癌症治疗手段之一。然而,PDT的应用仅限于浅表定位的人类癌性和癌前病变。为提高PDT和miRNA在癌症治疗中的效用,本研究调查了口腔癌中与凋亡相关的miRNA表达是否受PDT影响,以及miRNA是否能增强PDT疗效。为实现这一目标,我们使用脱镁叶绿酸a(Pa)作为光敏剂,基于miRNA阵列比较了PDT后与凋亡相关的miRNA表达模式。Pa-PDT后,13.1%的miRNA表达下调,16.7%的miRNA表达上调。根据表达差异选择代表性miRNA:miR-9-5p、miR-32-5p、miR-143-3p、miR-145-5p、miR-192-5p、miR-193a-5p、miR-204-5p、miR-212-3p、miR-338-3p和miR-451a。其中,只有miR-145-5p在Pa-PDT后的所有细胞系中均反复出现一致的降低。此外,miR-145-5p模拟物与Pa-PDT联合治疗增加了光毒性、活性氧生成和凋亡细胞死亡,表明miRNA表达可能是增强Pa-PDT治疗效果的有用标志物。本研究将为引入miRNA作为癌症治疗提供一种有前景的策略。